|
Exchange Disseminated Time | Orchid Chemicals & Pharmaceuticals Ltd has informed BSE regarding a Press Release titled "Orchid Pharma receives US FDA approval for Olanzapine Tabs ANDA".
Press Release:
"The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Olanzapine Tablets in the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths." (For more details kindly refer Corporate Announcements on www.bseindia.com). |
|
|